Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands (Q44549561)

4 December 2017

title

Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands (English)

1 reference

4 December 2017

0 references

0 references

Streptococcus pneumoniae

1 reference

K E M Elberse

1

1 reference

4 December 2017

S C de Greeff

2

1 reference

4 December 2017

N Wattimena

3

1 reference

4 December 2017

W Chew

4

1 reference

4 December 2017

C S Schot

5

1 reference

4 December 2017

J E van de Pol

6

1 reference

4 December 2017

J G J van der Heide

7

1 reference

4 December 2017

A van der Ende

8

1 reference

4 December 2017

F R M van der Klis

9

1 reference

4 December 2017

G A M Berbers

10

1 reference

4 December 2017

L M Schouls

11

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

4 December 2017

1 reference

4 December 2017

volume

29

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

1029-1035

1 reference

Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vacc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

The role of age in susceptibility to pneumococcal infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

The five-parameter logistic: a characterization and comparison with the four-parameter logistic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

A generalization of the probit and logit methods for dose response curves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Clonal Relationships between Invasive and Carriage Streptococcus pneumoniae and Serotype‐ and Clone‐Specific Differences in Invasive Disease Potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Elderly subjects do not show impaired pneumococcal capsular polysaccharide serotype-specific antibody responses as assessed by a multiplexed bead assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

The effect of age on the response to the pneumococcal polysaccharide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.054

10.1016/J.VACCINE.2010.11.054

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference